The genetic, epigenetic, and environmental etiologic basis of congenital heart disease (CHD) for most heart anomalies remains unexplained. In this issue of the JCI, Lahm et al. performed the largest genome-wide association study (GWAS) to date of European individuals with CHD and clinical subtypes. The comprehensive meta-analysis included over 4000 patients and 8000 controls and uncovered common genetic variants that associated with cardiac anomalies. Lahm and colleagues performed single-cell analysis of induced pluripotent stem cells and heart cells, revealing a role for MACROD2, GOSR2, WNT3, and MSX1 in the developing heart. This study advances our understanding of the genetic basis of common forms of CHD.
Dawood Darbar
Title and authors | Publication | Year |
---|---|---|
Deciphering Congenital Heart Disease Using Human Induced Pluripotent Stem Cells.
Zhang H, Wu JC |
Advances in experimental medicine and biology | 2024 |
Chromosomal abnormalities in fetuses with congenital heart disease: a meta-analysis.
Wang H, Lin X, Lyu G, He S, Dong B, Yang Y |
Archives of Gynecology and Obstetrics | 2023 |
Role of Vascular Endothelial Growth Factor as a Potential Biomarker in Congenital Heart Defects: A Systematic Review
Ashiq S, Hyder SN, Ashiq K, Sabar MF |
The Journal of Tehran University Heart Center | 2023 |